Loratadina ( DrugBank: Loratadina )

1 disease

ID	Disease name (Link within this page)	Number of trials
89	Lymphangioleiomyomatosis	1

89. Lymphangioleiomyomatosis

Clinical trials : 38 / Drugs : 38 - (DrugBank : 15) / Drug target genes : 18 - Drug target pathways : 118

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-000702-29-ES (EUCTR)	07/06/2021	09/02/2021	Evaluating the effect of Loratadine associated with Rapamune in Lymphagioleiomyomatosis (LAM).	Phase-II randomized clinical trial to evaluate the effect of Loratadine associated with Rapamune on ...	EFFECT OF LORATADINE ON LYMPHANGIOLEIOMYOMATOSIS MedDRA version: 21.0;Level: PT;Classification code ...	Trade Name: LoratadinaSTADA 10 mg Product Name: LoratadinaStada INN or Proposed INN: LORATADINE Other d ...	IDIBELL (Institut d’Investigació Biomédica de Bellvitge)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: no	62	Phase 2	Spain

First Previous1Next Last